Back to search results

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Abroad (travel likely)RecruitingPHASE2

Conditions

Major Depressive Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Harmonex /ID# 277517, Dothan, Alabama, United States

  • Ima Clinical Research Phoenix (Alea) /ID# 277516, Phoenix, Arizona, United States

  • Preferred Research Partners /ID# 279206, Little Rock, Arkansas, United States

  • Woodland International Research Group /ID# 277605, Little Rock, Arkansas, United States

  • Advanced Research Center /ID# 277537, Anaheim, California, United States

  • Sun Valley Research Center /ID# 277513, Imperial, California, United States

  • Synergy San Diego /ID# 277553, Lemon Grove, California, United States

  • Accellacare - Long Beach /ID# 279181, Long Beach, California, United States

  • CenExel CNR /ID# 277533, Sherman Oaks, California, United States

  • Inland Psychiatric Medical Group /ID# 279275, Temecula, California, United States

  • Sunwise Clinical Research /ID# 277555, Walnut Creek, California, United States

  • CenExel Hollywood FL /ID# 278200, Hollywood, Florida, United States

  • Cns Healthcare - Jacksonville /ID# 277658, Jacksonville, Florida, United States

  • GMI Florida - Central Miami Medical Institute /ID# 278218, Miami, Florida, United States

  • Clinical Neuroscience Solutions - Orlando - East South Street /ID# 277558, Orlando, Florida, United States

  • EquiPath Health & Research Tampa Bay, LLC /ID# 279128, Riverview, Florida, United States

  • Trialmed /ID# 277601, Atlanta, Georgia, United States

  • Evergreen Clinical Trials - Norcross /ID# 279421, Norcross, Georgia, United States

  • Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago, Illinois, United States

  • Amr Conventions Research /ID# 277547, Warrenville, Illinois, United States

  • Redbird Research /ID# 277485, Las Vegas, Nevada, United States

  • Ima Clinical Research - Manhattan /ID# 278212, New York, New York, United States

  • Manhattan Behavioral Medicine /ID# 277910, New York, New York, United States

  • Quest Therapeutics of Avon /ID# 277550, Avon Lake, Ohio, United States

  • OSU Psychiatry Department /ID# 277529, Columbus, Ohio, United States

  • Sooner Clinical Research /ID# 277659, Oklahoma City, Oklahoma, United States

  • Clinical Neuroscience Solutions /ID# 278192, Memphis, Tennessee, United States

  • Austin Clinical Trial Partners /ID# 279321, Austin, Texas, United States

  • Community Clinical Research - Cross Park Drive /ID# 277935, Austin, Texas, United States

  • Houston Clinical Trials - Bellaire /ID# 277551, Bellaire, Texas, United States

  • Pillar Clinical Research - Richardson /ID# 276764, Richardson, Texas, United States

  • Northwest Clinical Research Center /ID# 277484, Bellevue, Washington, United States

  • Core Clinical Research /ID# 277518, Everett, Washington, United States

Study leads

  • ABBVIE INC.

    Study Director

    AbbVie

View source on ClinicalTrials.gov(opens in a new tab)